PIM1 anticorps (C-Term)
Aperçu rapide pour PIM1 anticorps (C-Term) (ABIN5531842)
Antigène
Voir toutes PIM1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 374-404, C-Term
-
Purification
- This antibody is purified through a protein G column, followed by dialysis against PBS.
-
Immunogène
- This PIM1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 374-404 amino acids from the C-terminal region of human PIM1.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
-
For WB starting dilution is: 1:1000
For IHC-P starting dilution is: 1:50~100 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.27 mg/mL
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- PIM1 (Pim-1 Oncogene (PIM1))
-
Autre désignation
- PIM1
-
Sujet
- PIM1, which belongs to the Serine/Threonine protein kinase family, is thought to play a role in signal transduction in blood cells. The protooncogene PIM1 encodes a protein kinase upregulated in prostate cancer. It may affect the structure or silencing of chromatin by phosphorylating HP1 gamma/CBX3. PIM1 is expressed primarily in cells of the hematopoietic and germ line lineages.
-
Poids moléculaire
- 45 kDa
-
ID gène
- 5292
-
UniProt
- P11309
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-